| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $569,684 ) |
| 2024 | 2024 | ENVIVO BIO INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R33CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 001 | 3 | NIH | 7/25/2024 | $569,684 |
| 2024 | 2023 | ENVIVO BIO INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R33CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 000 | 2 | NIH | 3/29/2024 | $0 |
| 2024 | 2022 | ENVIVO BIO INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R21CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 000 | 1 | NIH | 11/2/2023 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $597,424 ) |
| 2023 | 2023 | ENVIVO BIO INC | 26160 RANCHO MANUELLA LN | LOS ALTOS HILLS | CA | 94022-2034 | SANTA CLARA | USA | R33CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 000 | 2 | NIH | 8/18/2023 | $597,424 |
| 2023 | 2022 | ENVIVO BIO INC | 26160 RANCHO MANUELLA LN | LOS ALTOS HILLS | CA | 94022-2034 | SANTA CLARA | USA | R21CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 000 | 1 | NIH | 7/12/2023 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $221,819 ) |
| 2022 | 2022 | ENVIVO BIO INC. | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R21CA260665 | Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring | 000 | 1 | NIH | 3/24/2022 | $221,819 |
|
|